Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge.

Priya NoriKelsie CowmanVictor ChenRachel BartashWendy SzymczakTheresa MadalineChitra Punjabi KatiyarRuchika JainMargaret AldrichGregory WestonPhilip GialanellaMarilou CorpuzInessa GendlinaYi Guo

Published in: Infection control and hospital epidemiology (2020)

We observed bacterial or fungal coinfections in COVID-19 patients admitted between March 1 and April 18, 2020 (152 of 4,267, 3.6%). Among these patients, mortality was 57%; 74% were intubated; 51% with bacteremia had central venous catheters. Time to culture positivity was 6-7 days, and 79% had received prior antibiotics. Metallo-β-lactamase-producing E. cloacae coinfections occurred in 5 patients.

Keyphrases

end stage renal disease
sars cov
coronavirus disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
cardiovascular disease
type diabetes
risk factors
cardiovascular events